ReviewTranslational cancer research2026
Current status and advances in research on the impact and mechanisms of atmospheric pollutants on gastric cancer: a narrative review.
Review in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Asiatic acid remodels the gastric precancerous immune microenvironment by targeting STING.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Gastric cancer (GC) constitutes a significant global health issue, with its incidence and mortality rates ranking fifth worldwide. In recent years, atmospheric pollutants, as one of the environmental factors, have increasingly been recognized as critical risk factors in the development of GC. Epidemiological studies indicate that atmospheric pollutants such as particulate matter, gaseous pollutants, polycyclic aromatic hydrocarbons, and persistent organic substances are associated with the onset and progression of GC. Currently, the pathogenic mechanisms by which atmospheric pollutants contribute to GC remain incompletely elucidated. These mechanisms may involve pathways such as inflammatory responses, oxidative stress, immunomodulation, metabolism, gut microbiota interactions, and genetic cross-talk, all of which promote the development and progression of GC. Additionally, this article summarizes the current limitations of research and outlines future research directions, aiming to provide a reference for future studies. Methods: This study conducted a literature review by searching the PubMed and Web of Science databases to identify the latest research findings regarding the mechanisms by which atmospheric pollutants promote the occurrence and development of GC. Based on these findings, a narrative review was generated. Key Content and Findings: This article introduces the classification of major atmospheric pollutants and epidemiological studies on their association with GC. It summarizes the mechanisms by which atmospheric pollutants promote the occurrence and development of GC. In addition, it also summarizes the limitations of current research and future research directions. These advances will help provide more theoretical basis for the role of atmospheric pollutants in promoting the development of GC. Conclusions: Atmospheric pollutants can promote the occurrence and development of GC through pathways such as inflammatory response, oxidative stress, immune regulation, metabolism, intestinal microecology, and genetic interaction. In the future, more extensive epidemiological studies and more in-depth mechanism research are needed to further explore the mechanisms by which atmospheric pollutants contribute to GC. Meanwhile, this will also be beneficial to the formulation of relevant public health policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.